EDP-514

DRUG4 trials

Sponsors

Enanta Pharmaceuticals, Inc

Conditions

Chronic HBV InfectionChronic Hepatitis B Virus InfectionHepatitis B

Phase 1

A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2)

CompletedNCT04008004

Enanta Pharmaceuticals, IncChronic HBV Infection

Start: 2019-06-26End: 2021-07-14Updated: 2022-01-11

A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment

CompletedNCT04470388

Enanta Pharmaceuticals, IncChronic HBV Infection

Start: 2020-09-09End: 2021-08-30Updated: 2022-01-11

Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy Subjects

CompletedNCT04783753

Enanta Pharmaceuticals, IncHepatitis B

Start: 2020-11-05End: 2021-07-09Updated: 2021-08-16

A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION.

TerminatedNCT04971512

Enanta Pharmaceuticals, IncChronic Hepatitis B Virus Infection

Start: 2021-08-02End: 2021-12-20Updated: 2022-02-14